0515T
|
Insertion of wireless cardiac stimulator for left ventricular pacing, including device interrogation and programming, and imaging supervision and interpretation, when performed; complete system (includes electrode and generator [transmitter and battery])
|
0516T
|
Insertion of wireless cardiac stimulator for left ventricular pacing, including device interrogation and programming, and imaging supervision and interpretation, when performed; electrode only
|
0517T
|
Insertion of wireless cardiac stimulator for left ventricular pacing, including device interrogation and programming, and imaging supervision and interpretation, when performed; both components of pulse generator (battery and transmitter) only
|
0518T
|
Removal of pulse generator for wireless cardiac stimulator for left ventricular pacing; battery component only
|
0519T
|
Removal and replacement of pulse generator for wireless cardiac stimulator for left ventricular pacing, including device interrogation and programming; both components (battery and transmitter)
|
0520T
|
Removal and replacement of pulse generator for wireless cardiac stimulator for left ventricular pacing, including device interrogation and programming; battery component only
|
0521T
|
Interrogation device evaluation (in person) with analysis, review and report, includes connection, recording, and disconnection per patient encounter, wireless cardiac stimulator for left ventricular pacing
|
0522T
|
Programming device evaluation (in person) with iterative adjustment of the implantable device to test the function of the device and select optimal permanent programmed values with analysis, including review and report, wireless cardiac stimulator for left ventricular pacing
|
10040
|
Acne surgery (e.g., marsupialization, opening or removal of multiple milia, comedones, cysts, pustules)
|
11920
|
Tattooing, intradermal introduction of insoluble opaque pigments to correct color defects of skin, including micropigmentation; 6.0 sq cm or less
|
11921
|
Tattooing, intradermal introduction of insoluble opaque pigments to correct color defects of skin, including micropigmentation; 6.1 to 20.0 sq cm
|
11922
|
Tattooing, intradermal introduction of insoluble opaque pigments to correct color defects of skin, including micropigmentation; each additional 20.0 sq cm, or part thereof (List separately in addition to code for primary procedure)
|
11971
|
Removal of tissue expander without insertion of implant
|
14000
|
Adjacent tissue transfer or rearrangement, trunk; defect 10 sq cm or less
|
14001
|
Adjacent tissue transfer or rearrangement, trunk; defect 10.1 sq cm to 30.0 sq cm
|
14041
|
Adjacent tissue transfer or rearrangement, forehead, cheeks, chin, mouth, neck, axillae, genitalia, hands and/or feet; defect 10.1 sq cm to 30.0 sq cm
|
15730
|
Transfer, intermediate, of any pedicle flap (e.g., abdomen to wrist, Walking tube), any location
|
15738
|
Muscle, myocutaneous, or fasciocutaneous flap; lower extremity
|
15750
|
Flap; neurovascular pedicle
|
15757
|
Free skin flap with microvascular anastomosis
|
15758
|
Free fascial flap with microvascular anastomosis
|
26340
|
Manipulation, finger joint, under anesthesia, each joint
|
28890
|
Extracorporeal shock wave, high energy, performed by a physician or other qualified health care professional, requiring anesthesia other than local, including ultrasound guidance, involving the plantar fascia
|
33251
|
Operative ablation of supraventricular arrhythmogenic focus or pathway (e.g., Wolff-Parkinson-White, atrioventricular node re-entry), tract(s) and/or focus (foci); with cardiopulmonary bypass
|
33254
|
Operative tissue ablation and reconstruction of atria, limited (e.g., modified maze procedure)
|
33255
|
Operative tissue ablation and reconstruction of atria, extensive (e.g., maze procedure); without cardiopulmonary bypass
|
33256
|
Operative tissue ablation and reconstruction of atria, extensive (e.g., maze procedure); with cardiopulmonary bypass
|
33257
|
Operative tissue ablation and reconstruction of atria, performed at the time of other cardiac procedure(s), limited (e.g., modified maze procedure) (List separately in addition to code for primary procedure)
|
33258
|
Operative tissue ablation and reconstruction of atria, performed at the time of other cardiac procedure(s), extensive (e.g., maze procedure), without cardiopulmonary bypass (List separately in addition to code for primary procedure)
|
33259
|
Operative tissue ablation and reconstruction of atria, performed at the time of other cardiac procedure(s), extensive (e.g., maze procedure), with cardiopulmonary bypass (List separately in addition to code for primary procedure)
|
33261
|
Operative ablation of ventricular arrhythmogenic focus with cardiopulmonary bypass
|
33276
|
Insertion of phrenic nerve stimulator system (pulse generator and stimulating lead[s]), including vessel catheterization, all imaging guidance, and pulse generator initial analysis with diagnostic mode activation, when performed
|
33277
|
Insertion of phrenic nerve stimulator transvenous sensing lead (List separately in addition to code for primary procedure)
|
33278
|
Removal of phrenic nerve stimulator, including vessel catheterization, all imaging guidance, and interrogation and programming, when performed; system, including pulse generator and lead(s)
|
33279
|
Removal of phrenic nerve stimulator, including vessel catheterization, all imaging guidance, and interrogation and programming, when performed; transvenous stimulation or sensing lead(s) only
|
33280
|
Removal of phrenic nerve stimulator, including vessel catheterization, all imaging guidance, and interrogation and programming, when performed; pulse generator only
|
33281
|
Repositioning of phrenic nerve stimulator transvenous lead(s)
|
33287
|
Removal and replacement of phrenic nerve stimulator, including vessel catheterization, all imaging guidance, and interrogation and programming, when performed; pulse generator
|
33288
|
Removal and replacement of phrenic nerve stimulator, including vessel catheterization, all imaging guidance, and interrogation and programming, when performed; transvenous stimulation or sensing lead(s)
|
33361
|
Transcatheter aortic valve replacement (TAVR/TAVI) with prosthetic valve; percutaneous femoral artery approach
|
33362
|
Transcatheter aortic valve replacement (TAVR/TAVI) with prosthetic valve; open femoral artery approach
|
33363
|
Transcatheter aortic valve replacement (TAVR/TAVI) with prosthetic valve; open axillary artery approach
|
33364
|
Transcatheter aortic valve replacement (TAVR/TAVI) with prosthetic valve; open iliac artery approach
|
33365
|
Transcatheter aortic valve replacement (TAVR/TAVI) with prosthetic valve; transaortic approach (e.g., median sternotomy, mediastinotomy)
|
33366
|
Transcatheter aortic valve replacement (TAVR/TAVI) with prosthetic valve; transapical exposure (e.g., left thoracotomy)
|
33369
|
Transcatheter aortic valve replacement (TAVR/TAVI) with prosthetic valve; cardiopulmonary bypass support with central arterial and venous cannulation (e.g., aorta, right atrium, pulmonary artery) (List separately in addition to code for primary procedure)
|
33404
|
Construction of apical-aortic conduit
|
33414
|
Repair of left ventricular outflow tract obstruction by patch enlargement of the outflow tract
|
33415
|
Resection or incision of subvalvular tissue for discrete subvalvular aortic stenosis
|
33416
|
Ventriculomyotomy (-myectomy) for idiopathic hypertrophic subaortic stenosis (e.g., asymmetric septal hypertrophy)
|
33417
|
Aortoplasty (gusset) for supravalvular stenosis
|
33476
|
Tricuspid valve repositioning and plication for Ebstein anomaly
|
33477
|
Transcatheter pulmonary valve implantation, percutaneous approach, including pre-stenting of the valve delivery site, when performed
|
33478
|
Outflow tract augmentation (gusset), with or without commissurotomy or infundibular resection
|
33500
|
Repair of coronary arteriovenous or arteriocardiac chamber fistula; with cardiopulmonary bypass
|
33501
|
Repair of coronary arteriovenous or arteriocardiac chamber fistula; without cardiopulmonary bypass
|
33502
|
Repair of anomalous coronary artery from pulmonary artery origin; by ligation
|
33503
|
Repair of anomalous coronary artery from pulmonary artery origin; by graft, without cardiopulmonary bypass
|
33504
|
Repair of anomalous coronary artery from pulmonary artery origin; by graft, with cardiopulmonary bypass
|
33505
|
Repair of anomalous coronary artery from pulmonary artery origin; with construction of intrapulmonary artery tunnel (Takeuchi procedure)
|
33506
|
Repair of anomalous coronary artery from pulmonary artery origin; by translocation from pulmonary artery to aorta
|
33507
|
Repair of anomalous (e.g., intramural) aortic origin of coronary artery by unroofing or translocation
|
33600
|
Closure of atrioventricular valve (mitral or tricuspid) by suture or patch
|
33602
|
Closure of semilunar valve (aortic or pulmonary) by suture or patch
|
33606
|
Anastomosis of pulmonary artery to aorta (Damus-Kaye-Stansel procedure)
|
33608
|
Repair of complex cardiac anomaly other than pulmonary atresia with ventricular septal defect by construction or replacement of conduit from right or left ventricle to pulmonary artery
|
33610
|
Repair of complex cardiac anomalies (e.g., single ventricle with subaortic obstruction) by surgical enlargement of ventricular septal defect
|
33611
|
Repair of double outlet right ventricle with intraventricular tunnel repair
|
33612
|
Repair of double outlet right ventricle with intraventricular tunnel repair; with repair of right ventricular outflow tract obstruction
|
33615
|
Repair of complex cardiac anomalies (e.g., tricuspid atresia) by closure of atrial septal defect and anastomosis of atria or vena cava to pulmonary artery (simple Fontan procedure)
|
33617
|
Repair of complex cardiac anomalies (e.g., single ventricle) by modified Fontan procedure
|
33619
|
Repair of single ventricle with aortic outflow obstruction and aortic arch hypoplasia (hypoplastic left heart syndrome) (e.g., Norwood procedure)
|
33641
|
Repair atrial septal defect, secundum, with cardiopulmonary bypass, with or without patch
|
33645
|
Direct or patch closure, sinus venosus, with or without anomalous pulmonary venous drainage
|
33647
|
Repair of atrial septal defect and ventricular septal defect, with direct or patch closure
|
33660
|
Repair of incomplete or partial atrioventricular canal (ostium primum atrial septal defect), with or without atrioventricular valve repair
|
33665
|
Repair of intermediate or transitional atrioventricular canal, with or without atrioventricular valve repair
|
33670
|
Repair of complete atrioventricular canal, with or without prosthetic valve
|
33675
|
Closure of multiple ventricular septal defects
|
33676
|
Closure of multiple ventricular septal defects; with pulmonary valvotomy or infundibular resection (acyanotic)
|
33677
|
Closure of multiple ventricular septal defects; with removal of pulmonary artery band, with or without gusset
|
33681
|
Closure of single ventricular septal defect, with or without patch
|
33684
|
Closure of single ventricular septal defect, with or without patch; with pulmonary valvotomy or infundibular resection (acyanotic)
|
33688
|
Closure of single ventricular septal defect, with or without patch; with removal of pulmonary artery band, with or without gusset
|
33690
|
Banding of pulmonary artery
|
33692
|
Complete repair tetralogy of Fallot without pulmonary atresia;
|
33694
|
Complete repair tetralogy of Fallot without pulmonary atresia; with transannular patch
|
33697
|
Complete repair tetralogy of Fallot with pulmonary atresia including construction of conduit from right ventricle to pulmonary artery and closure of ventricular septal defect
|
33702
|
Repair sinus of Valsalva fistula, with cardiopulmonary bypass;
|
33710
|
Repair sinus of Valsalva fistula, with cardiopulmonary bypass; with repair of ventricular septal defect
|
33720
|
Repair sinus of Valsalva aneurysm, with cardiopulmonary bypass
|
33724
|
Repair of isolated partial anomalous pulmonary venous return (e.g., Scimitar Syndrome)
|
33726
|
Repair of pulmonary venous stenosis
|
33730
|
Complete repair of anomalous pulmonary venous return (supracardiac, intracardiac, or infracardiac types)
|
33732
|
Repair of cor triatriatum or supravalvular mitral ring by resection of left atrial membrane
|
33735
|
Atrial septectomy or septostomy; closed heart (Blalock-Hanlon type operation)
|
33736
|
Atrial septectomy or septostomy; open heart with cardiopulmonary bypass
|
33750
|
Shunt; subclavian to pulmonary artery (Blalock-Taussig type operation)
|
33755
|
Shunt; ascending aorta to pulmonary artery (Waterston type operation)
|
33762
|
Shunt; descending aorta to pulmonary artery (Potts-Smith type operation)
|
33764
|
Shunt; central, with prosthetic graft
|
33766
|
Shunt; superior vena cava to pulmonary artery for flow to 1 lung (classical Glenn procedure)
|
33767
|
Shunt; superior vena cava to pulmonary artery for flow to both lungs (bidirectional Glenn procedure)
|
33768
|
Anastomosis, cavopulmonary, second superior vena cava (List separately in addition to primary procedure)
|
33770
|
Repair of transposition of the great arteries with ventricular septal defect and subpulmonary stenosis; without surgical enlargement of ventricular septal defect
|
33771
|
Repair of transposition of the great arteries with ventricular septal defect and subpulmonary stenosis; with surgical enlargement of ventricular septal defect
|
33774
|
Repair of transposition of the great arteries, atrial baffle procedure (e.g., Mustard or Senning type) with cardiopulmonary bypass
|
33775
|
Repair of transposition of the great arteries, atrial baffle procedure (e.g., Mustard or Senning type) with cardiopulmonary bypass; with removal of pulmonary band
|
33776
|
Repair of transposition of the great arteries, atrial baffle procedure (e.g., Mustard or Senning type) with cardiopulmonary bypass; with closure of ventricular septal defect
|
33777
|
Repair of transposition of the great arteries, atrial baffle procedure (e.g., Mustard or Senning type) with cardiopulmonary bypass; with repair of subpulmonic obstruction
|
33778
|
Repair of transposition of the great arteries, aortic pulmonary artery reconstruction (e.g., Jatene type)
|
33779
|
Repair of transposition of the great arteries, aortic pulmonary artery reconstruction (e.g., Jatene type); with removal of pulmonary band
|
33780
|
Repair of transposition of the great arteries, aortic pulmonary artery reconstruction (e.g., Jatene type); with closure of ventricular septal defect
|
33781
|
Repair of transposition of the great arteries, aortic pulmonary artery reconstruction (e.g., Jatene type); with repair of subpulmonic obstruction
|
33786
|
Total repair, truncus arteriosus (Rastelli type operation)
|
33788
|
Reimplantation of an anomalous pulmonary artery
|
33802
|
Division of aberrant vessel (vascular ring)
|
33803
|
Division of aberrant vessel (vascular ring); with reanastomosis
|
33820
|
Repair of patent ductus arteriosus; by ligation
|
33822
|
Repair of patent ductus arteriosus; by division, younger than 18 years
|
33840
|
Excision of coarctation of aorta, with or without associated patent ductus arteriosus; with direct anastomosis
|
33845
|
Excision of coarctation of aorta, with or without associated patent ductus arteriosus; with graft
|
33851
|
Excision of coarctation of aorta, with or without associated patent ductus arteriosus; repair using either left subclavian artery or prosthetic material as gusset for enlargement
|
33852
|
Repair of hypoplastic or interrupted aortic arch using autogenous or prosthetic material; without cardiopulmonary bypass
|
33853
|
Repair of hypoplastic or interrupted aortic arch using autogenous or prosthetic material; with cardiopulmonary bypass
|
33917
|
Repair of pulmonary artery stenosis by reconstruction with patch or graft
|
33920
|
Repair of pulmonary atresia with ventricular septal defect, by construction or replacement of conduit from right or left ventricle to pulmonary artery
|
33924
|
Ligation and takedown of a systemic-to-pulmonary artery shunt, performed in conjunction with a congenital heart procedure (List separately in addition to code for primary procedure)
|
33927
|
Implantation of a total replacement heart system (artificial heart) with recipient cardiectomy
|
33928
|
Removal and replacement of total replacement heart system (artificial heart)
|
33929
|
Removal of a total replacement heart system (artificial heart) for heart transplantation (List separately in addition to code for primary procedure)
|
36514
|
Therapeutic apheresis; for plasma pheresis
|
61850
|
Twist drill or burr hole(s) for implantation of neurostimulator electrodes, cortical
|
61863
|
Twist drill, burr hole, craniotomy, or craniectomy with stereotactic implantation of neurostimulator electrode array in subcortical site (e.g., thalamus, globus pallidus, subthalamic nucleus, periventricular, periaqueductal gray), without use of intraoperative microelectrode recording; first array
|
61864
|
Twist drill, burr hole, craniotomy, or craniectomy with stereotactic implantation of neurostimulator electrode array in subcortical site (e.g., thalamus, globus pallidus, subthalamic nucleus, periventricular, periaqueductal gray), without use of intraoperative microelectrode recording; each additional array (List separately in addition to primary procedure)
|
61867
|
Twist drill, burr hole, craniotomy, or craniectomy with stereotactic implantation of neurostimulator electrode array in subcortical site (e.g., thalamus, globus pallidus, subthalamic nucleus, periventricular, periaqueductal gray), with use of intraoperative microelectrode recording; first array
|
61868
|
Twist drill, burr hole, craniotomy, or craniectomy with stereotactic implantation of neurostimulator electrode array in subcortical site (e.g., thalamus, globus pallidus, subthalamic nucleus, periventricular, periaqueductal gray), with use of intraoperative microelectrode recording; each additional array (List separately in addition to primary procedure)
|
61885
|
Insertion or replacement of cranial neurostimulator pulse generator or receiver, direct or inductive coupling; with connection to a single electrode array
|
61886
|
Insertion or replacement of cranial neurostimulator pulse generator or receiver, direct or inductive coupling; with connection to a single electrode array
|
61892
|
Removal of skull-mounted cranial neurostimulator pulse generator or receiver with cranioplasty, when performed
|
64405
|
Injection, anesthetic agent; greater occipital nerve
|
64570
|
Removal of cranial nerve (e.g., vagus nerve) neurostimulator electrode array and pulse generator
|
64595
|
Revision or removal of peripheral, sacral, or gastric neurostimulator pulse generator or receiver, with detachable connection to electrode array
|
64744
|
Transection or avulsion of; greater occipital nerve
|
64856
|
Suture of major peripheral nerve, arm or leg, except sciatic; including transposition
|
64892
|
Nerve graft (includes obtaining graft), single strand, arm or leg; up to 4 cm length
|
64896
|
Nerve graft (includes obtaining graft), multiple strands (cable), hand or foot; more than 4 cm length
|
65765
|
Keratophakia
|
65767
|
Epikeratoplasty
|
66180
|
Aqueous shunt to extraocular equatorial plate reservoir, external approach; with graft
|
67909
|
Reduction of overcorrection of ptosis
|
67912
|
Correction of lagophthalmos, with implantation of upper eyelid lid load (e.g., gold weight)
|
67914
|
Repair of ectropion; suture
|
67915
|
Repair of ectropion; thermocauterization
|
67916
|
Repair of ectropion; excision tarsal wedge
|
67917
|
Repair of ectropion; extensive (e.g., tarsal strip operations)
|
67921
|
Repair of entropion; suture
|
67922
|
Repair of entropion; thermocauterization
|
67923
|
Repair of entropion; excision tarsal wedge
|
67924
|
Repair of entropion; extensive (e.g., tarsal strip or capsulopalpebral fascia repairs operation)
|
67961
|
Excision and repair of eyelid, involving lid margin, tarsus, conjunctiva, canthus, or full thickness, may include preparation for skin graft or pedicle flap with adjacent tissue transfer or rearrangement; up to one-fourth of lid margin
|
69728
|
Removal, entire osseointegrated implant, skull; with magnetic transcutaneous attachment to external speech processor, outside the mastoid and involving a bony defect greater than or equal to 100 sq mm surface area of bone deep to the outer cranial cortex
|
69729
|
Implantation, osseointegrated implant, skull; with magnetic transcutaneous attachment to external speech processor, outside of the mastoid and resulting in removal of greater than or equal to 100 sq mm surface area of bone deep to the outer cranial cortex
|
69730
|
Replacement (including removal of existing device), osseointegrated implant, skull; with magnetic transcutaneous attachment to external speech processor, outside the mastoid and involving a bony defect greater than or equal to 100 sq mm surface area of bone deep to the outer cranial cortex
|
76983
|
Ultrasound, elastography; each additional target lesion (List separately in addition to code for primary procedure)
|
81105
|
Human Platelet Antigen 1 genotyping (HPA-1), ITGB3 (integrin, beta 3 [platelet glycoprotein IIIa], antigen CD61 [GPIIIa]) (e.g., neonatal alloimmune thrombocytopenia [NAIT], post-transfusion purpura), gene analysis, common variant, HPA-1a/b (L33P)
|
81106
|
Human Platelet Antigen 2 genotyping (HPA-2), GP1BA (glycoprotein Ib [platelet], alpha polypeptide [GPIba]) (e.g., neonatal alloimmune thrombocytopenia [NAIT], post- transfusion purpura), gene analysis, common variant, HPA-2a/b (T145M)
|
81107
|
Human Platelet Antigen 3 genotyping (HPA-3), ITGA2B (integrin, alpha 2b [platelet glycoprotein IIb of IIb/IIIa complex], antigen CD41 [GPIIb]) (e.g., neonatal alloimmune thrombocytopenia [NAIT], post-transfusion purpura), gene analysis, common variant, HPA-3a/b (I843S)
|
81108
|
Human Platelet Antigen 4 genotyping (HPA-4), ITGB3 (integrin, beta 3 [platelet glycoprotein IIIa], antigen CD61 [GPIIIa]) (e.g., neonatal alloimmune thrombocytopenia [NAIT], post-transfusion purpura), gene analysis, common variant, HPA-4a/b (R14)
|
81109
|
Human Platelet Antigen 5 genotyping (HPA-5), ITGA2 (integrin, alpha 2 [CD49B, alpha 2 subunit of VLA-2 receptor] [GPIa]) (e.g., neonatal alloimmune thrombocytopenia [NAIT], post-transfusion purpura), gene analysis, common variant (e.g., HPA-5a/b (K505E)
|
81110
|
Human Platelet Antigen 6 genotyping (HPA-6w), ITGB3 (integrin, beta 3 [platelet glycoprotein IIIa, antigen CD61] [GPIIIa])(e.g., neonatal alloimmune thrombocytopenia [NAIT], post-transfusion purpura), gene analysis, common variant, HPA-6a/b (R489Q)
|
81111
|
Human Platelet Antigen 9 genotyping (HPA-9w), ITGA2B (integrin, alpha 2b [platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41] [GPIIb]) (e.g., neonatal alloimmune thrombocytopenia [NAIT], post-transfusion purpura), gene analysis, common variant, HPA-9a/b (V837M)
|
81120
|
IDH1 (isocitrate dehydrogenase 1 [NADP+], soluble) (e.g., glioma), common variants (e.g., R132H, R132C)
|
81121
|
IDH2 (isocitrate dehydrogenase 2 [NADP+], mitochondrial) (e.g., glioma), common variants (e.g., R140W, R172M)
|
81161
|
DMD (dystrophin) (e.g., Duchenne/Becker muscular dystrophy) deletion analysis, and duplication analysis, if performed
|
81170
|
ABL1 (ABL proto-oncogene 1, non-receptor tyrosine kinase) (e.g., acquired imatinib tyrosine kinase inhibitor resistance), gene analysis, variants in the kinase domain
|
81175
|
ASXL1 (additional sex combs like 1, transcriptional regulator) (e.g., myelodysplastic syndrome, myeloproliferative neoplasms, chronic myelomonocytic leukemia), gene analysis; full gene sequence
|
81176
|
ASXL1 (additional sex combs like 1, transcriptional regulator) (e.g., myelodysplastic syndrome, myeloproliferative neoplasms, chronic myelomonocytic leukemia), gene analysis; targeted sequence analysis (e.g., exon 12)
|
81200
|
ASPA (aspartoacylase) (e.g., Canavan disease) gene analysis, common variants (e.g., E285A, Y231X)
|
81205
|
BCKDHB (branched-chain keto acid dehydrogenase E1, beta polypeptide) (e.g., maple syrup urine disease) gene analysis, common variants (e.g., R183P, G278S, E422X)
|
81206
|
BCR/ABL1 (t(9;22)) (e.g., chronic myelogenous leukemia) translocation analysis; major breakpoint, qualitative or quantitative
|
81207
|
BCR/ABL1 (t(9;22)) (e.g., chronic myelogenous leukemia) translocation analysis; minor breakpoint, qualitative or quantitative
|
81208
|
BCR/ABL1 (t(9;22)) (e.g., chronic myelogenous leukemia) translocation analysis; other breakpoint, qualitative or quantitative
|
81209
|
BLM (Bloom syndrome, RecQ helicase-like) (e.g., Bloom syndrome) gene analysis, 2281del6ins7 variant
|
81210
|
BRAF (B-Raf proto-oncogene, serine/threonine kinase) (e.g., colon cancer, melanoma), gene analysis, V600 variant(s)
|
81218
|
CEBPA (CCAAT/enhancer binding protein [C/EBP], alpha) (e.g., acute myeloid leukemia), gene analysis, full gene sequence
|
81219
|
CALR (calreticulin) (e.g., myeloproliferative disorders), gene analysis, common variants in exon 9
|
81220
|
CFTR (cystic fibrosis transmembrane conductance regulator) (e.g., cystic fibrosis) gene analysis; common variants (e.g., ACMG/ACOG guidelines)
|
81221
|
CFTR (cystic fibrosis transmembrane conductance regulator) (e.g., cystic fibrosis) gene analysis; known familial variants
|
81222
|
CFTR (cystic fibrosis transmembrane conductance regulator) (e.g., cystic fibrosis) gene analysis; duplication/deletion variants
|
81223
|
CFTR (cystic fibrosis transmembrane conductance regulator) (e.g., cystic fibrosis) gene analysis; full gene sequence
|
81224
|
CFTR (cystic fibrosis transmembrane conductance regulator) (e.g., cystic fibrosis) gene analysis; intron 8 poly-T analysis (e.g., male infertility)
|
81228
|
Cytogenomic (genome-wide) analysis for constitutional chromosomal abnormalities; interrogation of genomic regions for copy number variants, comparative genomic hybridization [CGH] microarray analysis
|
81229
|
Cytogenomic (genome-wide) analysis for constitutional chromosomal abnormalities; interrogation of genomic regions for copy number and single nucleotide polymorphism (SNP) variants, comparative genomic
|
81235
|
EGFR (epidermal growth factor receptor) (e.g., non-small cell lung cancer) gene analysis, common variants (e.g., exon 19 LREA deletion, L858R, T790M, G719A, G719S, L861Q)
|
81240
|
F2 (prothrombin, coagulation factor II) (e.g., hereditary hypercoagulability) gene analysis, 20210G>A variant
|
81241
|
F5 (coagulation factor V) (e.g., hereditary hypercoagulability) gene analysis, Leiden variant
|
81242
|
FANCC (Fanconi anemia, complementation group C) (e.g., Fanconi anemia, type C) gene analysis, common variant (e.g., IVS4+4A>T)
|
81243
|
FMR1 (fragile X messenger ribonucleoprotein 1) (e.g., fragile X syndrome, X-linked intellectual disability [XLID]) gene analysis; evaluation to detect abnormal (e.g., expanded) alleles
|
81244
|
FMR1 (fragile X messenger ribonucleoprotein 1) (e.g., fragile X syndrome, X-linked intellectual disability [XLID]) gene analysis; characterization of alleles (e.g., expanded size and promoter methylation status)
|
81245
|
FLT3 (fms-related tyrosine kinase 3) (e.g., acute myeloid leukemia), gene analysis; internal tandem duplication (ITD) variants (i.e., exons 14, 15)
|
81246
|
FLT3 (fms-related tyrosine kinase 3) (e.g., acute myeloid leukemia), gene analysis; tyrosine kinase domain (TKD) variants (e.g., D835, I836)
|
81247
|
G6PD (glucose-6-phosphate dehydrogenase) (e.g., hemolytic anemia, jaundice), gene analysis; common variant(s) (e.g., A, A-)
|
81250
|
G6PC (glucose-6-phosphatase, catalytic subunit) (e.g., Glycogen storage disease, type 1a, von Gierke disease) gene analysis, common variants (e.g., R83C, Q347X)
|
81251
|
GBA (glucosidase, beta, acid) (e.g., Gaucher disease) gene analysis, common variants (e.g., N370S, 84GG, L444P, IVS2+1G>A)
|
81252
|
GJB2 (gap junction protein, beta 2, 26kDa, connexin 26) (e.g., nonsyndromic hearing loss) gene analysis; full gene sequence
|
81254
|
GJB6 (gap junction protein, beta 6, 30kDa, connexin 30) (e.g., nonsyndromic hearing loss) gene analysis, common variants (e.g., 309kb [del(GJB6-D13S1830)] and 232kb [del(GJB6-D13S1854)])
|
81255
|
HEXA (hexosaminidase A [alpha polypeptide]) (e.g., Tay-Sachs disease) gene analysis, common variants (e.g., 1278insTATC, 1421+1G>C, G269S)
|
81256
|
HFE (hemochromatosis) (e.g., hereditary hemochromatosis) gene analysis, common variants (e.g., C282Y, H63D)
|
81257
|
HBA1/HBA2 (alpha globin 1 and alpha globin 2) (e.g., alpha thalassemia, Hb Bart hydrops fetalis syndrome, HbH disease), gene analysis, for common deletions or variant (e.g., Southeast Asian, Thai, Filipino, Mediterranean, alpha3.7, alpha4.2, alpha20.5, and Constant Spring)
|
81259
|
HBA1/HBA2 (alpha globin 1 and alpha globin 2)(e.g., alpha thalassemia, Hb Bart hydrops fetalis syndrome, HbH disease), gene analysis; full gene sequence
|
81260
|
HBA1/HBA2 (alpha globin 1 and alpha globin 2)(e.g., alpha thalassemia, Hb Bart hydrops fetalis syndrome, HbH disease), gene analysis; full gene sequence
|
81261
|
IGH@ (Immunoglobulin heavy chain locus) (e.g., leukemias and lymphomas, B-cell), gene rearrangement analysis to detect abnormal clonal population(s); amplified methodology (e.g., polymerase chain reaction)
|
81262
|
IGH@ (Immunoglobulin heavy chain locus) (e.g., leukemias and lymphomas, B-cell), gene rearrangement analysis to detect abnormal clonal population(s); direct probe methodology (e.g., Southern blot)
|
81263
|
IGH@ (Immunoglobulin heavy chain locus) (e.g., leukemia and lymphoma, B-cell), variable region somatic mutation analysis
|
81264
|
IGK@ (Immunoglobulin kappa light chain locus) (e.g., leukemia and lymphoma, B-cell), gene rearrangement analysis, evaluation to detect abnormal clonal population(s)
|
81265
|
Comparative analysis using Short Tandem Repeat (STR) markers; patient and comparative specimen (e.g., pre-transplant recipient and donor germline testing, post-transplant non-hematopoietic recipient germline [e.g., buccal swab or other germline tissue sample] and donor testing, twin zygosity testing, or maternal cell contamination of fetal cells)
|
81266
|
Comparative analysis using Short Tandem Repeat (STR) markers; each additional specimen (e.g., additional cord blood donor, additional fetal samples from different cultures, or additional zygosity in multiple birth pregnancies) (List separately in addition to code for primary procedure)
|
81267
|
Chimerism (engraftment) analysis, post transplantation specimen (e.g., hematopoietic stem cell), includes comparison to previously performed baseline analyses; without cell selection
|
81268
|
Chimerism (engraftment) analysis, post transplantation specimen (e.g., hematopoietic stem cell), includes comparison to previously performed baseline analyses; with cell selection (e.g., CD3, CD33), each cell type
|
81269
|
HBA1/HBA2 (alpha globin 1 and alpha globin 2)(e.g., alpha thalassemia, Hb Bart hydrops fetalis syndrome, HbH disease), gene analysis; duplication/deletion variants
|
81270
|
JAK2 (Janus kinase 2) (e.g., myeloproliferative disorder) gene analysis, p.Val617Phe (V617F) variant
|
81272
|
KIT (v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog) (e.g., gastrointestinal stromal tumor [GIST], acute myeloid leukemia, melanoma), gene analysis, targeted sequence analysis (e.g., exons 8, 11, 13, 17, 18)
|
81273
|
KIT (v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog) (e.g., mastocytosis), gene analysis, D816 variant(s)
|
81275
|
KRAS (Kirsten rat sarcoma viral oncogene homolog) (e.g., carcinoma) gene analysis; variants in exon 2 (e.g., codons 12 and 13)
|
81276
|
KRAS (Kirsten rat sarcoma viral oncogene homolog) (e.g., carcinoma) gene analysis; additional variant(s) (e.g., codon 61, codon 146)
|
81277
|
Cytogenomic neoplasia (genome-wide) microarray analysis, interrogation of genomic regions for copy number and loss-of-heterozygosity variants for chromosomal abnormalities
|
81283
|
IFNL3 (interferon, lambda 3) (e.g., drug response), gene analysis, rs12979860 variant
|
81287
|
MGMT (O-6-methylguanine-DNA methyltransferase) (e.g., glioblastoma multiforme), methylation analysis
|
81288
|
MLH1 (mutL homolog 1, colon cancer, nonpolyposis type 2) (e.g., hereditary non-polyposis colorectal cancer, Lynch syndrome) gene analysis; promoter methylation analysis
|
81290
|
MCOLN1 (mucolipin 1) (e.g., Mucolipidosis, type IV) gene analysis, common variants (e.g., IVS3-2A>G, del6.4kb)
|
81291
|
MTHFR (5,10-methylenetetrahydrofolate reductase) (e.g., hereditary hypercoagulability) gene analysis, common variants (e.g., 677T, 1298C)
|
81292
|
MLH1 (mutL homolog 1, colon cancer, nonpolyposis type 2) (e.g., hereditary non-polyposis colorectal cancer, Lynch syndrome) gene analysis; full sequence analysis
|
81293
|
MLH1 (mutL homolog 1, colon cancer, nonpolyposis type 2) (e.g., hereditary non-polyposis colorectal cancer, Lynch syndrome) gene analysis; known familial variants
|
81294
|
MLH1 (mutL homolog 1, colon cancer, nonpolyposis type 2) (e.g., hereditary non-polyposis colorectal cancer, Lynch syndrome) gene analysis; duplication/deletion variants
|
81295
|
MSH2 (mutS homolog 2, colon cancer, nonpolyposis type 1) (e.g., hereditary non-polyposis colorectal cancer, Lynch syndrome) gene analysis; full sequence analysis
|
81296
|
MSH2 (mutS homolog 2, colon cancer, nonpolyposis type 1) (e.g., hereditary non-polyposis colorectal cancer, Lynch syndrome) gene analysis; known familial variants
|
81297
|
MSH2 (mutS homolog 2, colon cancer, nonpolyposis type 1) (e.g., hereditary non-polyposis colorectal cancer, Lynch syndrome) gene analysis; duplication/deletion variants
|
81298
|
MSH6 (mutS homolog 6 [E. coli]) (e.g., hereditary non-polyposis colorectal cancer, Lynch syndrome) gene analysis; full sequence analysis
|
81299
|
MSH6 (mutS homolog 6 [E. coli]) (e.g., hereditary non-polyposis colorectal cancer, Lynch syndrome) gene analysis; known familial variants
|
81300
|
MSH6 (mutS homolog 6 [E. coli]) (e.g., hereditary non-polyposis colorectal cancer, Lynch syndrome) gene analysis; duplication/deletion variants
|
81301
|
Microsatellite instability analysis (e.g., hereditary non-polyposis colorectal cancer, Lynch syndrome) of markers for mismatch repair deficiency (e.g., BAT25, BAT26), includes comparison of neoplastic and normal tissue, if performed
|
81302
|
MECP2 (methyl CpG binding protein 2) (e.g., Rett syndrome) gene analysis; full sequence analysis
|
81304
|
MECP2 (methyl CpG binding protein 2) (e.g., Rett syndrome) gene analysis; duplication/deletion variants
|
81309
|
PIK3CA (phosphatidylinositol-4, 5-biphosphate 3-kinase, catalytic subunit alpha) (e.g., colorectal and breast cancer) gene analysis, targeted sequence analysis (e.g., exons 7, 9, 20)
|
81310
|
NPM1 (nucleophosmin) (e.g., acute myeloid leukemia) gene analysis, exon 12 variants
|
81311
|
NRAS (neuroblastoma RAS viral [v-ras] oncogene homolog) (e.g., colorectal carcinoma), gene analysis, variants in exon 2 (e.g., codons 12 and 13) and exon 3 (e.g., codon 61)
|
81314
|
PDGFRA (platelet-derived growth factor receptor, alpha polypeptide) (e.g., gastrointestinal stromal tumor [GIST]), gene analysis, targeted sequence analysis (e.g., exons 12, 18)
|
81315
|
PML/RARalpha, (t(15;17)), (promyelocytic leukemia/retinoic acid receptor alpha) (e.g., promyelocytic leukemia) translocation analysis; common breakpoints (e.g., intron 3 and intron 6), qualitative or quantitative
|
81316
|
PML/RARalpha, (t(15;17)), (promyelocytic leukemia/retinoic acid receptor alpha) (e.g., promyelocytic leukemia) translocation analysis; single breakpoint (e.g., intron 3, intron 6 or exon 6), qualitative or quantitative
|
81317
|
PMS2 (postmeiotic segregation increased 2 [S. cerevisiae]) (e.g., hereditary non-polyposis colorectal cancer, Lynch syndrome) gene analysis; full sequence analysis
|
81319
|
PMS2 (postmeiotic segregation increased 2 [S. cerevisiae]) (e.g., hereditary non-polyposis colorectal cancer, Lynch syndrome) gene analysis; duplication/deletion variants
|
81324
|
PMP22 (peripheral myelin protein 22) (e.g., Charcot-Marie-Tooth, hereditary neuropathy with liability to pressure palsies) gene analysis; duplication/deletion analysis
|
81330
|
SMPD1(sphingomyelin phosphodiesterase 1, acid lysosomal) (e.g., Niemann-Pick disease, Type A) gene analysis, common variants (e.g., R496L, L302P, fsP330)
|
81331
|
SNRPN/UBE3A (small nuclear ribonucleoprotein polypeptide N and ubiquitin protein ligase E3A) (e.g., Prader-Willi syndrome and/or Angelman syndrome), methylation analysis
|
81332
|
SERPINA1 (serpin peptidase inhibitor, clade A, alpha-1 antiproteinase, antitrypsin, member 1) (e.g., alpha-1-antitrypsin deficiency), gene analysis, common variants (e.g., *S and *Z)
|
81334
|
RUNX1 (runt related transcription factor 1) (e.g., acute myeloid leukemia, familial platelet disorder with associated myeloid malignancy), gene analysis, targeted sequence analysis (e.g., exons 3-8)
|
81335
|
TPMT(thiopurine S-methyltransferase) (e.g., drug metabolism), gene analysis, common variants (e.g., *2, *3)
|
81340
|
TRB@ (T cell antigen receptor, beta) (e.g., leukemia and lymphoma), gene rearrangement analysis to detect abnormal clonal population(s); using amplification methodology (e.g., polymerase chain reaction)
|
81341
|
TRB@ (T cell antigen receptor, beta) (e.g., leukemia and lymphoma), gene rearrangement analysis to detect abnormal clonal population(s); using direct probe methodology (e.g., Southern blot)
|
81342
|
TRG@ (T cell antigen receptor, gamma) (e.g., leukemia and lymphoma), gene rearrangement analysis, evaluation to detect abnormal clonal population(s)
|
81346
|
TYMS (thymidylate synthetase) (e.g., 5-fluorouracil/5-FU drug metabolism), gene analysis, common variant(s) (e.g., tandem repeat variant)
|
81349
|
Cytogenomic (genome-wide) analysis for constitutional chromosomal abnormalities; interrogation of genomic regions for copy number and loss-of-heterozygosity variants, low-pass sequencing analysis
|
81350
|
UGT1A1 (UDP glucuronosyltransferase 1 family, polypeptide A1) (e.g., irinotecan metabolism), gene analysis, common variants (e.g., *28, *36, *37)
|
81351
|
TP53 (tumor protein 53) (e.g., Li-Fraumeni syndrome) gene analysis; full gene sequence
|
81353
|
TP53 (tumor protein 53) (e.g., Li-Fraumeni syndrome) gene analysis; known familial variant
|
81355
|
VKORC1 (vitamin K epoxide reductase complex, subunit 1) (e.g., warfarin metabolism), gene analysis, common variant(s) (e.g., -1639G>A, c.173+1000C>T)
|
81361
|
HBB (hemoglobin, subunit beta) (e.g., sickle cell anemia, beta thalassemia, hemoglobinopathy); common variant(s) (e.g., HbS, HbC, HbE)
|
81363
|
HBB (hemoglobin, subunit beta) (e.g., sickle cell anemia, beta thalassemia, hemoglobinopathy); duplication/deletion variant(s)
|
81370
|
HLA Class I and II typing, low resolution (e.g., antigen equivalents); HLA-A, -B, -C, -DRB1/3/4/5, and -DQB1
|
81371
|
HLA Class I and II typing, low resolution (e.g., antigen equivalents); HLA-A, -B, and -DRB1 (e.g., verification typing)
|
81372
|
HLA Class I typing, low resolution (e.g., antigen equivalents); complete (i.e., HLA-A, -B, and -C)
|
81373
|
HLA Class I typing, low resolution (e.g., antigen equivalents); one locus (e.g., HLA-A, -B, or -C), each
|
81374
|
HLA Class I typing, low resolution (e.g., antigen equivalents); one antigen equivalent (e.g., B*27), each
|
81375
|
HLA Class II typing, low resolution (e.g., antigen equivalents); HLA-DRB1/3/4/5 and -DQB1
|
81376
|
HLA Class II typing, low resolution (e.g., antigen equivalents); one locus (e.g., HLA-DRB1, -DRB3/4/5, -DQB1, -DQA1, -DPB1, or -DPA1), each
|
81377
|
HLA Class II typing, low resolution (e.g., antigen equivalents); one antigen equivalent, each
|
81378
|
HLA Class I and II typing, high resolution (i.e., alleles or allele groups), HLA-A, -B, -C, and -DRB1
|
81379
|
HLA Class I typing, high resolution (i.e., alleles or allele groups); complete (i.e., HLA-A, -B, and -C)
|
81380
|
HLA Class I typing, high resolution (i.e., alleles or allele groups); one locus (e.g., HLA-A, -B, or -C), each
|
81381
|
HLA Class I typing, high resolution (i.e., alleles or allele groups); one allele or allele group (e.g., B*57:01P), each
|
81382
|
HLA Class II typing, high resolution (i.e., alleles or allele groups); one locus (e.g., HLA-DRB1, -DRB3/4/5, -DQB1, -DQA1, -DPB1, or -DPA1), each
|
81383
|
HLA Class II typing, high resolution (i.e., alleles or allele groups); one allele or allele group (e.g., HLA-DQB1*06:02P), each
|
81411
|
Aortic dysfunction or dilation (e.g., Marfan syndrome, Loeys Dietz syndrome, Ehler Danlos syndrome type IV, arterial tortuosity syndrome); duplication/deletion analysis panel, must include analyses for TGFBR1, TGFBR2, MYH11, and COL3A1
|
81414
|
Cardiac ion channelopathies (e.g., Brugada syndrome, long QT syndrome, short QT syndrome, catecholaminergic polymorphic ventricular tachycardia); duplication/deletion gene analysis panel, must include analysis of at least 2 genes, including KCNH2 and KCNQ1
|
81435
|
Hereditary colon cancer-related disorders (e.g., Lynch syndrome, PTEN hamartoma syndrome, Cowden syndrome, familial adenomatosis polyposis), genomic sequence analysis panel, 5 or more genes, interrogation for sequence variants and copy number variants
|
81596
|
Infectious disease, chronic hepatitis C virus (HCV) infection, six biochemical assays (ALT, A2-macroglobulin, apolipoprotein A-1, total bilirubin, GGT, and haptoglobin) utilizing serum, prognostic algorithm reported as scores for fibrosis and necroinflammatory activity in liver
|
93581
|
Percutaneous transcatheter closure of a congenital ventricular septal defect with implant
|
93595
|
Left heart catheterization for congenital heart defect(s) including imaging guidance by the proceduralist to advance the catheter to the target zone, normal or abnormal native connections
|
93750
|
Interrogation of ventricular assist device (VAD), in person
|
95965
|
Magnetoencephalography (MEG), recording and analysis; for spontaneous brain magnetic activity (e.g., epileptic cerebral cortex localization)
|
95966
|
Magnetoencephalography (MEG), recording and analysis; for evoked magnetic fields, single modality (e.g., sensory, motor, language, or visual cortex localization)
|
95980
|
Electronic analysis of implanted neurostimulator pulse generator system (e.g., rate, pulse amplitude and duration, configuration of wave form, battery status, electrode selectability, output modulation, cycling, impedance and patient measurements) gastric neurostimulator pulse generator/transmitter; intraoperative, with programming
|
95981
|
Electronic analysis of implanted neurostimulator pulse generator system (e.g., rate, pulse amplitude and duration, configuration of wave form, battery status, electrode selectability, output modulation, cycling, impedance and patient measurements) gastric neurostimulator pulse generator/transmitter; subsequent, without reprogramming
|
95982
|
Electronic analysis of implanted neurostimulator pulse generator system (e.g., rate, pulse amplitude and duration, configuration of wave form, battery status, electrode selectability, output modulation, cycling, impedance and patient measurements) gastric neurostimulator pulse generator/transmitter; subsequent, with reprogramming
|
A4563
|
Rectal control system for vaginal insertion, for long term use, includes pump and all supplies and accessories, any type each
|
A9285
|
Inversion/eversion correction device
|
C1825
|
Generator, neurostimulator (implantable), non-rechargeable with carotid sinus baroreceptor stimulation lead(s)
|
C9758
|
Blinded procedure for NYHA Class III/IV heart failure; transcatheter implantation of interatrial shunt or placebo control, including right heart catheterization, transesophageal echocardiography (TEE)/intracardiac echocardiography (ICE), and all imaging with or without guidance (e.g., ultrasound, fluoroscopy), performed in an approved investigational device exemption (IDE) study
|
C9782
|
Blinded procedure for New York Heart Association (NYHA) class II or III heart failure, or Canadian Cardiovascular Society (CCS) class III or IV chronic refractory angina; transcatheter intramyocardial transplantation of autologous bone marrow cells (e.g., mononuclear) or placebo control, autologous bone marrow harvesting and preparation for transplantation, left heart catheterization including ventriculography, all laboratory services, and all imaging with or without guidance (e.g., transthoracic echocardiography, ultrasound, fluoroscopy), performed in an approved investigational device exemption (IDE) study
|
C9783
|
Blinded procedure for transcatheter implantation of coronary sinus reduction device or placebo control, including vascular access and closure, right heart catheterization, venous and coronary sinus angiography, imaging guidance and supervision and interpretation when performed in an approved investigational device exemption (IDE) study
|
E0217
|
Water circulating heat pad with pump
|
L8042
|
Orbital prosthesis, provided by a nonphysician
|